Unaudited Condensed Consolidated Statements of Stockholders' Investment - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance - beginning of period (in shares)			39,611,163
Balance-beginning of period	$ 322,543	$ 400,179	$ 291,515	$ 391,036
Balance - beginning of period (in shares)			26,317,947
Net income	25,573	25,192	$ 89,633	156,654
Issuance of shares through the Company's equity plans	617	468	1,525	2,465
Purchase of shares under the stock repurchase program	(9,049)	(117,850)	(38,458)	(238,327)
Settlement of net share equity awards	(12)		(2,081)	(3,177)
Cash dividends declared, per common share	(3,202)	(3,694)	(9,707)	(7,540)
Stock-based compensation	$ 1,364	$ 1,190	$ 5,407	$ 4,373
Balance - ending of period (in shares)	39,847,656	39,587,012	39,847,656	39,587,012
Balance-end of period	$ 337,834	$ 305,485	$ 337,834	$ 305,485
Balance - end of period (in shares)	27,161,181	25,900,206	27,161,181	25,900,206
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance - beginning of period (in shares)	39,830,000	39,578,000	39,611,000	39,380,000
Balance-beginning of period	$ 398	$ 396	$ 396	$ 394
Issuance of shares through the Company's equity plans (in shares)	18,000	9,000	236,000	207,000
Issuance of shares through the Company's equity plans			$ 2	$ 2
Balance - ending of period (in shares)	39,848,000	39,587,000	39,848,000	39,587,000
Balance-end of period	$ 398	$ 396	$ 398	$ 396
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	207,678	199,713	202,729	194,534
Issuance of shares through the Company's equity plans	617	468	1,523	2,463
Stock-based compensation	1,364	1,190	5,407	4,373
Balance-end of period	209,659	201,370	209,659	201,370
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	1,079,872	986,568	1,022,317	858,951
Net income	25,573	25,192	89,633	156,654
Cash dividends declared, per common share	(3,202)	(3,694)	(9,707)	(7,540)
Balance-end of period	1,102,243	1,008,066	1,102,243	1,008,066
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ (965,405)	$ (786,498)	$ (933,927)	$ (662,843)
Balance - beginning of period (in shares)	27,000,000	24,473,000	26,318,000	22,901,000
Purchase of shares under the stock repurchase program (in shares)	161,000	1,427,000	797,000	2,954,000
Purchase of shares under the stock repurchase program	$ (9,049)	$ (117,850)	$ (38,458)	$ (238,327)
Settlement of net share equity awards (in shares)			46,000	45,000
Settlement of net share equity awards	(12)		$ (2,081)	$ (3,177)
Balance-end of period	$ (974,466)	$ (904,347)	$ (974,466)	$ (904,347)
Balance - end of period (in shares)	27,161,000	25,900,000	27,161,000	25,900,000